by Complex regional pain syndrome (CRPS), also known as reflex sympathetic dystrophy syndrome (RSD), is a chronic pain condition that usually affects an arm or leg. It often begins with pain in the hand, wrist, or foot, usually after an injury, surgery, stroke or heart attack. Some typical symptoms include intense burning pain, increased sensitivity to touch or temperature changes, swelling, skin changes, changes in skin color and temperature asymmetry between the two limbs. The global complex regional pain syndrome market is primarily driven by the rising prevalence of CRPS across the globe owing to increasing incidences of fractures, bone injuries, and stroke. Additionally, technological advancements in the treatment of CRPS such as nerve block and spinal cord stimulation is further expected to drive the market growth over the forecast period.
The global Complex Regional Pain Syndrome Market is estimated to be valued at US$ 103.07 Mn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics
Rising Technological Advancements in Treatment: Technological advancements in the treatment of CRPS such as nerve block and spinal cord stimulation has presented lucrative opportunities for market growth. For instance, spinal cord stimulation involves use of a small device called a spinal cord stimulator which uses mild electrical impulses to block pain signals from reaching the brain. This non-drug therapy is found to be effective in controlling symptoms of CRPS such as burning pain, swelling and restricted joint movement. Similarly, nerve blocks involve injecting local anesthetics near injured or compressed nerves to temporarily interrupt pain signals traveling to the brain. Such advancements are expected to augment the demand for CRPS treatment over the forecast period.
Increased Awareness about Complex Regional Pain Syndrome: initiatives undertaken by government and non-profit organizations to spread awareness about complex regional pain syndrome is another major factor driving the market growth. For instance, Reflex Sympathetic Dystrophy Syndrome Association (RSDSA) regularly conducts awareness campaigns and educational programs to increase recognition of CRPS among general public as well as healthcare professionals. Such initiatives are helping more number of patients to get diagnosed and seek effective treatment options for complex regional pain syndrome.
Segment Analysis
The complex regional pain syndrome market can be segmented into primary and secondary segments based on its cause. Primary complex regional pain syndrome refers to pain that begins spontaneously after an injury. Secondary complex regional pain syndrome occurs after a physical trauma like fracture or surgery. Another popular segmentation divides the market into upper and lower limb complex regional pain syndrome. Typically, upper limb CRPS accounts for about 50-60% of the cases, making it the dominant segment. This is because the upper limbs are more prone to injuries from everyday activities involving use of hands and arms.
PEST Analysis
Political: Governments across developed nations are increasing funding for research on neuropathic pain conditions like CRPS due to growing disease burden. Favorable regulations encourage drug development.
Economic: Rising healthcare spending on chronic pain indicates patients’ readiness to spend on effective therapies. However, high treatment costs pose challenges to broader access in developing countries.
Social: Growing awareness helps improve timely diagnosis and management. With more people seeking specialized medical help, demand is steadily rising. Support groups also aid coping and rehabilitation.
Technological: Advancements in neuroimaging, targeted drug delivery, and non-invasive interventions are expanding options. Wearable pain sensors and virtual reality therapies offer promise but require further research.
Key Takeaways
The global Complex Regional Pain Syndrome Market Size is expected to witness high growth over the forecast period of 2023 to 2030, driven by increasing neurological disorder prevalence, novel drug approvals, and awareness programs.
Regional analysis: North America is a leading regional market for CRPS treatment. The U.S. accounts for majority share due to enhanced diagnosis and advanced pain management facilities. Europe also has a significant share due rising neurological disorders and favorable reimbursements inkey countries. However, Asia Pacific is expected to witness fastest growth on back of large patient pool, improving access to healthcare, and growing medical tourism.
Key players: Key players operating in the complex regional pain syndrome market are Intercos S.p.A., Kolmar Korea Co. Ltd., Scalpi Cosmética sa, Cosmecca Korea Co., Cosmax Inc., Mana Products Inc., KBL cosmetics Ltd., Urist Cosmetics Incorporated, Fareva Holding SA, Milliona Cosmetics Co., Ltd., Skinlys, Maesa SAS, Schwanhäusser Holding GmbH & Co. KG, Tricorbraun Inc., Herrco Cosmetics Limited, Architectural Beauty, Allure Labs Inc., Case Mason Filling, Inc., Pardaco Trading Pte Ltd, and KDC/ONE among others.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
